Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19
patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis …

Invasive pulmonary aspergillosis (IPA) remains difficult to diagnose and to treat. Most
common risk factors are prolonged neutropenia, hematopoietic stem cell or solid organ …

Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …

Background COVID-19-associated pulmonary aspergillosis (CAPA) has been reported to be
an emerging and potentially fatal complication of severe COVID-19. However, risk factors for …

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death
worldwide. In this review, we present the clinical spectrum and pathogenesis of syndromes …

A high level of suspicion in critically ill patients presenting with Aspergillus-positive
respiratory tract cultures or nonresolving pulmonary infection may lead to earlier IPA …

Serious fungal infections (SFI s) could be more frequent than are recognised. Estimates of
the incidence and prevalence of SFI s are essential in order to identify public health …

Aspergillus, Penicillium and related species reported from Turkey Page 1 1 Mycotaxon Vol.
89, No: 1, pp. 155-157, January-March, 2004. Journal home : http://www.mycotaxon.com …

Background Invasive pulmonary aspergillosis is increasingly identified as a complication of
influenza, termed 'influenza-associated pulmonary aspergillosis'(IAPA). Aims To assess the …

Chronic lung disease is recognized as an important risk factor for developing pulmonary
aspergillosis. The development of specific aspergillus-associated syndromes depends on …